Skip to content
The Nexus
DossierENTITY

CRISPR interference

Coverage of CRISPR interference in the Nexus archive.

Earliest in view: Apr 15 · 00:00 UTCMost recent: Apr 15 · 00:00 UTC
Co-mentioned in this coverage
PerturbFatetopic1Natureorganization1vemurafenibtopic1melanomatopic1
Recent coverage
  • SCIENCEApr 15 · 00:00 UTCNATURE NEWS
    Mapping convergent regulators of melanoma drug resistance by PerturbFate

    PerturbFate, a high-throughput single-cell platform, identifies common regulatory nodes and phenotypic states linked to vemurafenib resistance in melanoma cells. The study, published in Nature, uses CRISPR interference to map convergent regulators of drug resistance in melanoma.

CRISPR interference · Dossier · The Nexus